Dalpiciclib 150mg Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo120 enrolled2 locationsNCT07285382
Recruiting
Phase 1
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
Head and Neck Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06109207
Recruiting
Phase 1
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
Esophageal Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06225921